Cohort Study on Radioactive Iodine–Induced Hypothyroidism: Implications for Graves' Ophthalmopathy and Optimal Timing for Thyroid Hormone Assessment

MN Stan, JM Durski, JP Brito, S Bhagra, P Thapa… - Thyroid, 2013 - liebertpub.com
Background: Graves' ophthalmopathy (GO) develops or worsens in up to one-third of patients
treated with radioactive iodine (RAI) for Graves' hyperthyroidism. We sought to identify the …

18F-FDG PET and PET/CT in Burkitt's lymphoma

D Karantanis, JM Durski, VJ Lowe, MA Nathan… - European journal of …, 2010 - Elsevier
OBJECTIVE: To explore the value of 18 F fluorodeoxy-glucose (FDG) positron emission
tomography (PET) in Burkitt's lymphoma. METHODS: All Burkitt's lymphoma patients referred for …

The Value of [18F] Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Extranodal Natural Killer/T—Cell Lymphoma

…, PJ Peller, VJ Lowe, JM Durski… - Clinical Lymphoma and …, 2008 - Elsevier
Purpose To our knowledge, there are no published data pertinent to the use of [ 18 F]fluorodeoxyglucose
(FDG) positron emission tomography (PET)/computed tomography (CT) in …

Imaging of locally recurrent and metastatic thyroid cancer with positron emission tomography

PS CONTI, JM DURSKI, F BACQAI, ST GRAFTON… - Thyroid, 1999 - liebertpub.com
Serum thyroglobulin and imaging have been routinely used in the evaluation of thyroid cancer
patients suspected of having metastatic or recurrent disease. A more sensitive technique …

11C-Choline PET/CT for Detection and Localization of Parathyroid Adenomas

…, AH Goenka, JM Durski… - American Journal of …, 2018 - Am Roentgen Ray Soc
OBJECTIVE. The purpose of this study is to determine the efficacy of 11 C-choline PET/CT
for the detection of parathyroid adenomas by retrospectively reviewing a large patient …

Clinical outcomes of radioactive iodine redifferentiation therapy in previously iodine refractory differentiated thyroid cancers

…, JC Morris, C Hilger, C Peskey, JM Durski, M Ryder - Thyroid, 2024 - liebertpub.com
Objective: Redifferentiation therapy (RDT) can restore radioactive iodine (RAI) uptake in
differentiated thyroid cancer (DTC) cells to enable salvage 131 I therapy for previously RAI …

Comparison of FDG-PET and bone scans for detecting skeletal metastases in patients with non-small cell lung cancer

JM Durski, S Srinivas, G Segall - Clinical Positron Imaging, 2000 - Elsevier
Purpose: Positron Emission Tomography (PET) with F18-fluorodeoxyglucose has been
proven useful for staging non-small cell lung cancer. Bone scans are frequently performed for …

123I scan with whole-body retention measurement at 48 hours for simplified dosimetry before 131I treatment of metastatic thyroid cancer

JM Durski, CB Hruska, TV Bogsrud… - Clinical nuclear …, 2021 - journals.lww.com
A previously published model (Atkins) allows for calculation of 131 I maximum tolerated
activity on the basis of 48-hour whole-body retention of 131 I on a pretherapy diagnostic scan. …

Appendiceal carcinoid mimicking a Meckel's diverticulum on Tc-99m pertechnetate imaging

…, EV Loftus Jr, TJ Sebo, JM Durski - Clinical nuclear …, 2010 - journals.lww.com
A 47-year-old man with chronic abdominal pain presented with bloody diarrhea, fatigue,
nausea, and vomiting. A Tc-99m pertechnetate scan revealed focal increased radiotracer …

Nuclear medicine in evaluation and therapy of nodular thyroid

JM Durski, TV Bogsrud - Thyroid Nodules: Diagnosis and Management, 2018 - Springer
In current practice, thyroid scintigraphy is predominantly used for thyroid nodules in patients
with subnormal TSH. We present radiopharmaceuticals used for imaging and therapy and …